Chesapeake Biological Laboratories, Inc. Completes FDA Inspection at Baltimore Facility

Chesapeake Biological Laboratories, Inc. (Baltimore, MD) has successfully completed their initial FDA general facility cGMP (current Good Manufacturing Practices) inspection at their new sterile commercial production facility in the Camden Industrial Park in downtown Baltimore. The 71,000 square foot facility was designed and built out for large-scale formulation, filling and packaging of sterile pharmaceutical drugs in accordance with FDA regulations.

The facility is equipped with state-of-the-art filling equipment with the capacity to fill lots of up to 80,000 units. This commercial manufacturing site also houses a 120 square foot lyophilization chamber (freeze dryer).

At the announcement ceremonies, company officials boasted that the capacity of the new facility is more than five times as great as that which they currently possess, and is ready for the commercial production of sterile pharmaceutical products.

Chesapeake Biological Laboratories, Inc. provides sterile pharmaceutical and biopharmaceutical product development and commercial production services.

For more information: Joseph A. Twist, Chesapeake Biological Laboratories. Tel: 410-843-5000, fax: 410-843-4414.